BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28903739)

  • 1. Evolving DNA methylation and gene expression markers of B-cell chronic lymphocytic leukemia are present in pre-diagnostic blood samples more than 10 years prior to diagnosis.
    Georgiadis P; Liampa I; Hebels DG; Krauskopf J; Chatziioannou A; Valavanis I; de Kok TMCM; Kleinjans JCS; Bergdahl IA; Melin B; Spaeth F; Palli D; Vermeulen RCH; Vlaanderen J; Chadeau-Hyam M; Vineis P; Kyrtopoulos SA;
    BMC Genomics; 2017 Sep; 18(1):728. PubMed ID: 28903739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the nature of prediagnostic blood transcriptome markers of chronic lymphocytic leukemia by assessing their overlap with the transcriptome at the clinical stage.
    Vlaanderen J; Leenders M; Chadeau-Hyam M; Portengen L; Kyrtopoulos SA; Bergdahl IA; Johansson AS; Hebels DD; de Kok TM; Vineis P; Vermeulen RC
    BMC Genomics; 2017 Mar; 18(1):239. PubMed ID: 28320322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediagnostic transcriptomic markers of Chronic lymphocytic leukemia reveal perturbations 10 years before diagnosis.
    Chadeau-Hyam M; Vermeulen RC; Hebels DG; Castagné R; Campanella G; Portengen L; Kelly RS; Bergdahl IA; Melin B; Hallmans G; Palli D; Krogh V; Tumino R; Sacerdote C; Panico S; de Kok TM; Smith MT; Kleinjans JC; Vineis P; Kyrtopoulos SA;
    Ann Oncol; 2014 May; 25(5):1065-72. PubMed ID: 24558024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
    Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
    Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia.
    Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):111-117. PubMed ID: 33507687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell clones as early markers for chronic lymphocytic leukemia.
    Landgren O; Albitar M; Ma W; Abbasi F; Hayes RB; Ghia P; Marti GE; Caporaso NE
    N Engl J Med; 2009 Feb; 360(7):659-67. PubMed ID: 19213679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
    Wang LQ; Chim CS
    Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
    Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
    Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact.
    Tong WG; Wierda WG; Lin E; Kuang SQ; Bekele BN; Estrov Z; Wei Y; Yang H; Keating MJ; Garcia-Manero G
    Epigenetics; 2010 Aug; 5(6):499-508. PubMed ID: 20484983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.
    Casabonne D; Benavente Y; Seifert J; Costas L; Armesto M; Arestin M; Besson C; Hosnijeh FS; Duell EJ; Weiderpass E; Masala G; Kaaks R; Canzian F; Chirlaque MD; Perduca V; Mancini FR; Pala V; Trichopoulou A; Karakatsani A; La Vecchia C; Sánchez MJ; Tumino R; Gunter MJ; Amiano P; Panico S; Sacerdote C; Schmidt JA; Boeing H; Schulze MB; Barricarte A; Riboli E; Olsen A; Tjønneland A; Vermeulen R; Nieters A; Lawrie CH; de Sanjosé S
    Int J Cancer; 2020 Sep; 147(5):1315-1324. PubMed ID: 32012253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
    Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
    Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of key candidate genes and miRNA‑mRNA target pairs in chronic lymphocytic leukemia by integrated bioinformatics analysis.
    Gao C; Zhou C; Zhuang J; Liu L; Wei J; Liu C; Li H; Sun C
    Mol Med Rep; 2019 Jan; 19(1):362-374. PubMed ID: 30431072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.
    Cahill N; Bergh AC; Kanduri M; Göransson-Kultima H; Mansouri L; Isaksson A; Ryan F; Smedby KE; Juliusson G; Sundström C; Rosén A; Rosenquist R
    Leukemia; 2013 Jan; 27(1):150-8. PubMed ID: 22922567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
    Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
    J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.
    McCarthy BA; Yancopoulos S; Tipping M; Yan XJ; Wang XP; Bennett F; Li W; Lesser M; Paul S; Boyle E; Moreno C; Catera R; Messmer BT; Cutrona G; Ferrarini M; Kolitz JE; Allen SL; Rai KR; Rawstron AC; Chiorazzi N
    Immunol Res; 2015 Dec; 63(1-3):90-100. PubMed ID: 26318878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23.
    Kaaks R; Sookthai D; Łuczyńska A; Oakes CC; Becker S; Johnson T; Johansson A; Melin B; Sjöberg K; Trichopoulos D; Trichopoulou A; Lagiou P; Mattiello A; Tumino R; Masala G; Agnoli C; Boeing H; Aleksandrova K; Brennan P; Franceschi S; Roulland S; Casabonne D; de Sanjose S; Sánchez MJ; Huerta JM; Ardanaz E; Sala N; Overvad K; Tjønneland A; Halkjær J; Weiderpass E; Bueno-de-Mesquita HB; Vermeulen R; Peeters PH; Vineis P; Kelly RS; Khaw KT; Travis RC; Key TJ; Riboli E; Nieters A
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):538-45. PubMed ID: 25542829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.
    Negrini M; Cutrona G; Bassi C; Fabris S; Zagatti B; Colombo M; Ferracin M; D'Abundo L; Saccenti E; Matis S; Lionetti M; Agnelli L; Gentile M; Recchia AG; Bossio S; Reverberi D; Rigolin G; Calin GA; Sabbioni S; Russo G; Tassone P; Morabito F; Ferrarini M; Neri A
    Clin Cancer Res; 2014 Aug; 20(15):4141-53. PubMed ID: 24916701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.